tap water
Dietary Supplement300ml tap water via nasogastric tube
NCT Number: NCT02589613
The objective is to investigate neuro-anatomical correlates of the regulation of energy intake by means of functional MRI. Administration of glucose as well as fructose is followed by functional brain MRI, and findings are correlated with serum glucagon-like peptide 1 (GLP-1) levels as an endogenous satiety signal in obese humans.
Looking for future studies?
Notify Me18 year–45 year
Male
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
300ml tap water via nasogastric tube
300ml tap water with 75g Glucose via nasogastric tube
300ml tap water with 25g Fructose via nasogastric tube
Time frame: changes from baseline to one hour after treatment
Time frame: changes from baseline to one hour after treatment
Time frame: changes from baseline to one hour after treatment
Time frame: changes from baseline to one hour after treatment
University Hospital, Basel, Switzerland
Other
Effects of Acute Glucose and Fructose Ingestion on Brain Activity in Obese Volunteers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02902224
Behavior, Exploratory Behavior
Basel, Switzerland
View Trial DetailsNCT01875913
Behavior, Exploratory Behavior
Cambridge, Massachusetts, United States
View Trial DetailsNCT02255812
Behavior, Exploratory Behavior
Basel, Switzerland
View Trial DetailsNCT01918566
Behavior, Exploratory Behavior
Basel, Switzerland
View Trial Details